Sanara MedTech Inc.
SMTINasdaq
$25.00
↓ -1.3%Jul 17 close · end-of-day
Price
1Y↓ -10.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$224.6M
Enterprise Value
$257.3M
P/E
—
P/S
2.1
P/B
32.0
EV/EBITDA
20.5
PEG
—
FCF Yield
1.5%
Dividend Yield
—
Revenue (TTM)
$107.5M
Net Income (TTM)
$41.5M
Free Cash Flow (TTM)
$3.4M
Gross Margin
92.9%
Operating Margin
8.5%
Net Margin
38.7%
ROE
591.1%
ROIC
18.2%
Debt / Equity
6.6
Net Cash
-$32.6M
Return 1Y
-9.0%
Company profile
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel for the management of full and partial thickness wounds.
- CEO
- Zachary B. Fleming
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 60
- Headquarters
- Texas
- Website
- sanaramedtech.com
Management & directors
- Yon Seth DChief Executive Officer
- Waldrop Jacob A.Chief Operating Officer
- Mackey Ashley MController
- Taylor Elizabeth BChief Financial Officer
- Mcneil Michael D.Ch. Acct. & Ch. Admin. Officer
Roles derived from SEC Form 4 filings.
Earnings
SMTI Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$27.8M↑ +18.6%
Diluted EPS$0.05↓ -112.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $15.6M | $24.1M | $45.8M | $65.0M | $86.7M | $103.1M |
| Gross profit | $14.0M | $21.8M | $39.5M | $57.1M | $78.5M | $95.6M |
| Operating income | -$5.0M | -$7.4M | -$12.5M | -$4.2M | $1.3M | $7.3M |
| Net income | -$4.4M | -$7.9M | -$7.9M | $4.3M | $9.7M | $37.6M |
| Diluted EPS | -$0.76 | — | -$1.00 | -$0.52 | -$1.14 | -$4.36 |
| Operating cash flow | -$4.0M | -$4.8M | -$5.6M | -$3.2M | -$23,784.00 | $6.8M |
| Free cash flow | -$4.6M | -$5.0M | -$5.7M | -$3.5M | -$229,632.00 | $2.2M |
| Gross margin | 89.6% | 90.4% | 86.1% | 87.9% | 90.6% | 92.7% |
| Operating margin | -32.3% | -30.6% | -27.3% | -6.5% | 1.5% | 7.1% |
| Net margin | -28.5% | -32.8% | -17.3% | 6.6% | 11.2% | 36.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.2M | $21.7M | $26.3M | $23.4M | $25.8M | $26.3M | $27.5M | $27.8M |
| Gross profit | $18.2M | $19.7M | $24.1M | $21.6M | $23.9M | $24.5M | $25.6M | $25.9M |
| Operating income | -$2.9M | $778,537.00 | $4.9M | $825,530.00 | -$31,348.00 | $2.9M | $3.6M | $2.6M |
| Net income | -$3.5M | -$2.9M | $17.8M | -$3.5M | -$2.0M | -$30.4M | $73.5M | $458,957.00 |
| Diluted EPS | -$0.41 | -$0.34 | -$0.18 | -$0.41 | -$0.23 | -$3.40 | -$0.32 | $0.05 |
| Operating cash flow | -$1.4M | $2.1M | $932,047.00 | -$2.0M | $2.7M | $2.2M | $3.9M | -$2.5M |
| Free cash flow | -$1.5M | $2.0M | $859,875.00 | -$3.7M | $902,652.00 | $1.1M | $3.9M | -$2.5M |
| Gross margin | 90.0% | 90.8% | 91.4% | 92.2% | 92.5% | 92.9% | 93.2% | 93.1% |
| Operating margin | -14.3% | 3.6% | 18.6% | 3.5% | -0.1% | 11.2% | 13.0% | 9.5% |
| Net margin | -17.4% | -13.2% | 67.6% | -15.1% | -7.8% | -115.5% | 267.1% | 1.7% |
Company news
Jun 23, 2026
May 23, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-04 | Ortwein Sara N | Award | 4,616 | $0.00 | $0.00 | filing |
| 2026-06-04 | Mack Roszell III | Award | 5,308 | $0.00 | $0.00 | filing |
| 2026-06-04 | Salamone Ann Beal | Award | 4,154 | $0.00 | $0.00 | filing |
| 2026-06-04 | TANZBERGER ERIC D | Award | 5,308 | $0.00 | $0.00 | filing |
| 2026-06-04 | Nixon Ronald T | Award | 4,154 | $0.00 | $0.00 | filing |
| 2026-06-04 | DeSutter Robert Andrew | Award | 5,539 | $0.00 | $0.00 | filing |
| 2026-06-04 | Major Eric D | Award | 4,846 | $0.00 | $0.00 | filing |
| 2026-06-04 | Myers Keith G | Award | 4,385 | $0.00 | $0.00 | filing |
| 2026-05-15 | Yon Seth D· Chief Executive Officer | Tax withholding | 3,852 | $21.06 | $81,123.12 | filing |
| 2026-04-15 | Waldrop Jacob A.· Chief Operating Officer | Tax withholding | 378 | $20.01 | $7,563.78 | filing |
| 2026-03-22 | Waldrop Jacob A.· Chief Operating Officer | Award | 13,956 | $0.00 | $0.00 | filing |
| 2026-03-22 | Mackey Ashley M· Controller | Award | 2,804 | $0.00 | $0.00 | filing |
| 2026-03-22 | Mackey Ashley M· Controller | Award | 2,804 | $0.00 | $0.00 | filing |
| 2026-03-22 | Taylor Elizabeth B· Chief Financial Officer | Award | 12,687 | $0.00 | $0.00 | filing |
| 2026-03-22 | Yon Seth D· Chief Executive Officer | Award | 25,430 | $0.00 | $0.00 | filing |
| 2026-03-07 | Yon Seth D· Chief Executive Officer | Tax withholding | 596 | $18.87 | $11,246.52 | filing |
| 2026-03-01 | Yon Seth D· Chief Executive Officer | Tax withholding | 491 | $20.44 | $10,036.04 | filing |
| 2026-03-01 | Yon Seth D· Chief Executive Officer | Tax withholding | 414 | $20.44 | $8,462.16 | filing |
| 2026-02-25 | Yon Seth D· Chief Executive Officer | Tax withholding | 873 | $19.90 | $17,372.70 | filing |
| 2026-02-25 | Waldrop Jacob A.· Chief Operating Officer | Tax withholding | 714 | $19.90 | $14,208.60 | filing |
| 2026-02-25 | Taylor Elizabeth B· Chief Financial Officer | Tax withholding | 437 | $19.90 | $8,696.30 | filing |
| 2026-02-25 | Mackey Ashley M· Controller | Tax withholding | 149 | $19.90 | $2,965.10 | filing |
| 2025-09-15 | Yon Seth D· Chief Executive Officer | Award | 28,563 | $0.00 | $0.00 | filing |
| 2025-08-19 | McNeil Michael D.· Ch. Acct. & Ch. Admin. Officer | Tax withholding | 2,324 | $30.86 | $71,718.64 | filing |
Latest 24 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.